Currencies / AUTL
AUTL: Autolus Therapeutics plc - American Depositary Shares
2.42
USD
0.09
(3.59%)
AUTL exchange rate has changed by -3.59% for today. During the day, the instrument was traded at a low of 2.33 and at a high of 2.52.
Follow Autolus Therapeutics plc - American Depositary Shares dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
AUTL News
- Investing European Commission approves Autolus’ cell therapy for adult leukemia
- Benzinga FDA Eases Access To Life-Saving Gene Therapies For Blood Cancers - Johnson & Johnson (NYSE:JNJ), Novartis (NYSE:NVS), Gilead Sciences (NASDAQ:GILD), Bristol-Myers Squibb (NYSE:BMY)
- Investing obe-cel shows durable remission in r/r B-ALL patients at 3-year mark
- Investing Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel’s Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
- Investing Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel’s Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Con
- Investing Autolus at Goldman Sachs Conference: Strategic Focus on Alcatsol Launch
- Seeking Alpha Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market (AUTL)
- Investing Autolus shares surge 77% following InvestingPro’s April Fair Value signal
- Investing Credo Tech, Dollar General lead market cap stock movers on Tuesday
- Investing Autolus Therapeutics to Participate in Upcoming Investor Conferences
- Investing EMA committee endorses Autolus’ leukemia therapy obe-cel
- Investing Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress
- Seeking Alpha Autolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell Therapy (NASDAQ:AUTL)
Daily Range
2.33
2.52
Year Range
1.11
5.01
- Previous Close
- 2.51
- Open
- 2.51
- Bid
- 2.42
- Ask
- 2.72
- Low
- 2.33
- High
- 2.52
- Volume
- 3.498 K
- Daily Change
- -3.59%
- Month Change
- 7.08%
- 6 Months Change
- 10.00%
- Year Change
- -49.05%
30 July, Wednesday
12:15
USD
- Act
- 104 K
- Fcst
- 57 K
- Prev
- -33 K
12:30
USD
- Act
- 3.0%
- Fcst
- 0.4%
- Prev
- -0.5%
12:30
USD
- Act
- 2.0%
- Fcst
- 3.6%
- Prev
- 3.8%
12:30
USD
- Act
- 2.5%
- Fcst
- 3.3%
- Prev
- 3.5%
12:30
USD
- Act
- 2.1%
- Fcst
- 3.1%
- Prev
- 3.7%
12:30
USD
- Act
- 1.4%
- Fcst
- 0.8%
- Prev
- 0.5%
12:30
USD
- Act
- 6.3%
- Fcst
- -1.5%
- Prev
- -3.1%
14:00
USD
- Act
- Fcst
- 1.6%
- Prev
- 1.8%
14:00
USD
- Act
- Fcst
- 9.6%
- Prev
- 1.1%
14:00
USD
- Act
- Fcst
- Prev
- 72.6
14:30
USD
- Act
- Fcst
- 0.914 M
- Prev
- -3.169 M
14:30
USD
- Act
- Fcst
- 0.114 M
- Prev
- 0.455 M
14:30
USD
- Act
- Fcst
- 0.738 M
- Prev
- -0.740 M
14:30
USD
- Act
- Fcst
- -0.004 M
- Prev
- 0.095 M
14:30
USD
- Act
- Fcst
- -0.111 M
- Prev
- 2.931 M
14:30
USD
- Act
- Fcst
- 0.915 M
- Prev
- 0.282 M
14:30
USD
- Act
- Fcst
- 0.608 M
- Prev
- 0.003 M
14:30
USD
- Act
- Fcst
- 0.879 M
- Prev
- -1.738 M
14:30
USD
- Act
- Fcst
- Prev
- 0.087 M
14:30
USD
- Act
- Fcst
- Prev
- 1.6%
18:00
USD
- Act
- Fcst
- Prev
18:00
USD
- Act
- Fcst
- Prev
- 4.50%
18:30
USD
- Act
- Fcst
- Prev